First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Contraception

Volumn 87, Issue 1, 2013, Pages 26-37

  Raymond, Elizabeth G ^a   Shannon, Caitlin ^b   Weaver, Mark A ^c   Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Medical abortion; Mifepristone; Misoprostol; Systematic review

Indexed keywords

MEDABON; MIFEPRISTONE; MISOPROSTOL; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FIRST TRIMESTER ABORTION; GESTATIONAL AGE; HUMAN; MEDICAL ABORTION; MEDLINE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; DRUG THERAPY, COMBINATION; FEMALE; GESTATIONAL AGE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TREATMENT FAILURE;

EID: 84870924562     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.06.011     Document Type: Review

References (91)

1. R.K. Jones, and K. Kooistra Abortion incidence and access to services in the United States, 2008 Perspect Sex Reprod Health 43 2011 41 50
2. M. Niinimaki, A. Pouta, and A. Bloigu Immediate complications after medical compared with surgical termination of pregnancy Obstet Gynecol 114 2009 795 804
3. R.K. Jones, and S.K. Henshaw Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden Perspect Sex Reprod Health 34 2002 154 161
4. I. Sivin, J. Trussell, E.S. Lichtenberg, M. Fjerstad, K. Cleland, and V. Cullins Unexpected heaping in reported gestational age for women undergoing medical abortion Contraception 80 2009 287 291
5. A. Faundes The combination of mifepristone and misoprostol for the termination of pregnancy Int J Gynaecol Obstet 115 2011 1 4
6. World Health Organization. Safe abortion: technical and policy guidance for health systems 2nd ed. 2012 World Health Organization Geneva
7. Royal College of Obstetricians and Gynaecologists The care of women requesting induced abortion: evidence-based clinical guideline number 7 2011 RCOG Press London
8. K. Dahiya, S. Mann, and S. Nanda Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion Arch Gynecol Obstet 284 2011 59 63
9. M.D. Creinin, M.C. Fox, S. Teal, A. Chen, E.A. Schaff, and L.A. Meyn A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion Obstet Gynecol 103 2004 851 859
10. J.E. Norman, K.J. Thong, and D.T. Baird Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone Lancet 338 1991 1233 1236
11. M.A. Woldetsadik, T.Y. Sendekie, M.T. White, and D.T. Zegeye Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in Northwest Ethiopia Reprod Health 8 2011 19
12. W.H. Clark, D. Hassoun, K. Gemzell-Danielsson, C. Fiala, and B. Winikoff Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France Eur J Contracept Reprod Health Care 10 2005 184 191
13. T. Ashima, A. Vinita, and R. Shalini Early medical abortion: a new regimen up to 49 days' gestation Aust N Z J Obstet Gynaecol 45 2005 137 139
14. K.C. Singh, S. Ummat, S. Rajaram, and N. Goel First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study Aust N Z J Obstet Gynaecol 45 2005 495 498
15. M. Lin, Y.T. Li, and F.M. Chen Use of mifepristone and sublingual misoprostol for early medical abortion Taiwan J Obstet Gynecol 45 2006 321 324
16. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton Home self-administration of misoprostol for medical abortion up to 56 days' gestation J Fam Plann Reprod Health Care 31 2005 189 192
17. H. Hamoda, P.W. Ashok, J. Dow, G.M. Flett, and A. Templeton A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation Contraception 68 2003 335 338
18. O. Heikinheimo, R. Leminen, and S. Suhonen Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens Contraception 76 2007 456 460
19. A. Akin, J. Blum, and S. Ozalp Results and lessons learned from a small medical abortion clinical study in Turkey Contraception 70 2004 401 406
20. A. Akin, R. Dabash, and B. Dilbaz Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone Eur J Contracept Reprod Health Care 14 2009 169 175
21. P.W. Ashok, A. Templeton, P.T. Wagaarachchi, and G.M. Flett Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases Br J Obstet Gynaecol 109 2002 1281 1289
22. D.T. Baird, N. Sukcharoen, and K.J. Thong Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion Hum Reprod 10 1995 1521 1527
23. J. Bartley, A. Brown, R. Elton, and D.T. Baird Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation Hum Reprod 16 2001 2098 2102
24. M. Bhattachary A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE(2) gel (meteneprost) or 600 microg oral PGE(1) (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period. ICMR Task Force Study. Indian Council of Medical Research Contraception 62 2000 125 130
25. J. Blum, S. Hajri, H. Chelli, F.B. Mansour, N. Gueddana, and B. Winikoff The medical abortion experiences of married and unmarried women in Tunis, Tunisia Contraception 69 2004 63 69
26. A.A. Boersma, B. Meyboom-de Jong, and G. Kleiverda Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curacao Eur J Contracept Reprod Health Care 16 2011 61 66
27. H. Bracken, O. Gliozheni, and K. Kati Mifepristone medical abortion in Albania: results from a pilot clinical research study Eur J Contracept Reprod Health Care 11 2006 38 46
28. H. Bracken Home administration of misoprostol for early medical abortion in India Int J Gynaecol Obstet 108 2010 228 232
29. R. Chawdhary, A. Rana, and N. Pradhan Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial J Obstet Gynaecol Res 35 2009 78 85
30. N. Chuni, and T.S. Chandrashekhar Early pregnancy termination with a simplified mifepristone: medical abortion outpatient regimen Kathmandu Univ Med J 7 2009 209 212
31. W. Clark, H. Bracken, J. Tanenhaus, S. Schweikert, E.S. Lichtenberg, and B. Winikoff Alternatives to a routine follow-up visit for early medical abortion Obstet Gynecol 115 2010 264 272
32. K. Coyaji, U. Krishna, and S. Ambardekar Are two doses of misoprostol after mifepristone for early abortion better than one? Br J Obstet Gynaecol 114 2007 271 278
33. M.D. Creinin, C. Potter, and M. Holovanisin Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion Am J Obstet Gynecol 188 2003 664 669
34. M.D. Creinin, C.A. Schreiber, P. Bednarek, H. Lintu, M.S. Wagner, and L.A. Meyn Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial Obstet Gynecol 109 2007 885 894
35. K. Dahiya, S. Madan, R. Hooda, K. Sangwan, and A.H. Khosla Evaluation of the efficacy of mifepristone/misoprostol and methotrexate/misoprostol for medical abortion Indian J Med Sci 59 2005 301 306
36. A. Davis, C. Westhoff, and L. De Nonno Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration J Am Med Womens Assoc 55 2000 141 144
37. H. el-Refaey, and A. Templeton Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure Br J Obstet Gynaecol 101 1994 792 796
38. B. Elul, S. Hajri, N.N. Ngoc, C. Ellertson, C.B. Slama, E. Pearlman, and B. Winikoff Can women in less-developed countries use a simplified medical abortion regimen? Lancet 357 2001 1402 1405
39. M. Fekih, K. Fathallah, and L. Ben Regaya Sublingual misoprostol for first trimester termination of pregnancy Int J Gynaecol Obstet 109 2010 67 70
40. M.C. Fox, M.D. Creinin, and B. Harwood Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation Contraception 66 2002 225 229
41. A. Goel, S. Mittal, B.K. Taneja, N. Singal, and S. Attri Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial Arch Gynecol Obstet 283 2011 1409 1413
42. J. Guest, P.F. Chien, M.A. Thomson, and M.L. Kosseim Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol Br J Obstet Gynaecol 114 2007 207 215
43. S. Hajri, J. Blum, and N. Gueddana Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study Contraception 70 2004 487 491
44. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation Br J Obstet Gynaecol 112 2005 1102 1108
45. J.K. Jain, C. Dutton, B. Harwood, K.R. Meckstroth, and D.R. Mishell Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy Hum Reprod 17 2002 1477 1482
46. C. Karki, H. Pokharel, A. Kushwaha, D. Manandhar, H. Bracken, and B. Winikoff Acceptability and feasibility of medical abortion in Nepal Int J Gynaecol Obstet 106 2009 39 42
47. H. Kopp Kallner, C. Fiala, O. Stephansson, and K. Gemzell-Danielsson Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days Hum Reprod 25 2010 1153 1157
48. Y.T. Li, F.M. Chen, T.H. Chen, S.C. Li, M.L. Chen, and T.C. Kuo Concurrent use of mifepristone and misoprostol for early medical abortion Taiwan J Obstet Gynecol 45 2006 325 328
49. Y.T. Li, J.C. Hsieh, and G.Q. Hou Simultaneous use of mifepristone and misoprostol for early pregnancy termination Taiwan J Obstet Gynecol 50 2011 11 14
50. P.A. Lohr, M.F. Reeves, J.L. Hayes, B. Harwood, and M.D. Creinin Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study Contraception 76 2007 215 220
51. C. McKinley, K.J. Thong, and D.T. Baird The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol Hum Reprod 8 1993 1502 1505
52. T. Middleton, E. Schaff, and S.L. Fielding Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period Contraception 72 2005 328 332
53. S. Mundle, B. Elul, A. Anand, S. Kalyanwala, and S. Ughade Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center Contraception 76 2007 66 70
54. A.S. Murthy, M.D. Creinin, B. Harwood, and C. Schreiber A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation Contraception 71 2005 333 336
55. N.T. Ngoc, J. Blum, and S. Raghavan Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone Contraception 83 2011 410 417
56. N.T. Ngoc, V.Q. Nhan, J. Blum, T.T. Mai, J.M. Durocher, and B. Winikoff Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam Br J Obstet Gynaecol 111 2004 814 819
57. L.K. Perriera, M.F. Reeves, B.A. Chen, H.L. Hohmann, J. Hayes, and M.D. Creinin Feasibility of telephone follow-up after medical abortion Contraception 81 2010 143 149
58. R.H. Phelps, E.A. Schaff, and S.L. Fielding Mifepristone abortion in minors Contraception 64 2001 339 343
59. H.C. Pymar, M.D. Creinin, and J.L. Schwartz Mifepristone followed on the same day by vaginal misoprostol for early abortion Contraception 64 2001 87 92
60. S. Raghavan, R. Comendant, and I. Digol Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial Contraception 82 2010 513 519
61. S. Raghavan, R. Comendant, and I. Digol Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol Contraception 79 2009 84 90
62. G.W. Sang, L.J. Weng, and Q.X. Shao Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05 - a multicentre randomized clinical trial in China Contraception 50 1994 501 510
63. E.A. Schaff, S.H. Eisinger, L.S. Stadalius, P. Franks, B.Z. Gore, and S. Poppema Low-dose mifepristone 200 mg and vaginal misoprostol for abortion Contraception 59 1999 1 6
64. E.A. Schaff, S.L. Fielding, S. Eisinger, and L. Stadalius Mifepristone and misoprostol for early abortion when no gestational sac is present Contraception 63 2001 251 254
65. E.A. Schaff, S.L. Fielding, S.H. Eisinger, L.S. Stadalius, and L. Fuller Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days Contraception 61 2000 41 46
66. E.A. Schaff, S.L. Fielding, and C. Westhoff Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial JAMA 284 2000 1948 1953
67. E.A. Schaff, S.L. Fielding, and C. Westhoff Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy Contraception 66 2002 247 250
68. E.A. Schaff, S.L. Fielding, and C. Westhoff Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion Contraception 64 2001 81 85
69. C.A. Schreiber, M.D. Creinin, B. Harwood, and A.S. Murthy A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days Contraception 71 2005 447 450
70. C. Shannon, E. Wiebe, and F. Jacot Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial Br J Obstet Gynaecol 113 2006 621 628
71. C.S. Shannon, B. Winikoff, and R. Hausknecht Multicenter trial of a simplified mifepristone medical abortion regimen Obstet Gynecol 105 2005 345 351
72. Shrivastava Mifepristone and oral misoprostol for early medical abortion J Nepal Health Res Counc 7 2009 127 130
73. D. Takkar, N. Agarwal, R. Sehgal, and K. Buckshee Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin Adv Contracept 15 1999 163 173
74. O.S. Tang, C.C. Chan, E.H. Ng, S.W. Lee, and P.C. Ho A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation Hum Reprod 18 2003 2315 2318
75. O.S. Tang, P.P. Gao, L. Cheng, S. Lee, and P.C. Ho Pilot study on the use of a two-week course of oral misoprostol in patients after termination of pregnancy with mifepristone and misoprostol Contraception 57 1998 89 91
76. O.S. Tang, P.P. Gao, L. Cheng, S.W. Lee, and P.C. Ho A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol Hum Reprod 14 1999 722 725
77. O.S. Tang, S.W. Lee, and P.C. Ho A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone Hum Reprod 17 2002 2865 2868
78. O.S. Tang, J. Xu, L. Cheng, S.W. Lee, and P.C. Ho Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation Hum Reprod 17 2002 1738 1740
79. O.S. Tang, J. Xu, L. Cheng, S.W. Lee, and P.C. Ho The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial Hum Reprod 17 2002 99 102
80. K.J. Thong, and D.T. Baird Induction of abortion with mifepristone and misoprostol in early pregnancy Br J Obstet Gynaecol 99 1992 1004 1007
81. N.T. Tran, M.C. Jang, Y.S. Choe, W.S. Ko, H.S. Pyo, and O.S. Kim Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea Int J Gynaecol Obstet 109 2010 209 212
82. E.M. Tsai, C.H. Yang, and J.N. Lee Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women J Formos Med Assoc 101 2002 277 282
83. H. von Hertzen, H. Honkanen, and G. Piaggio WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy Br J Obstet Gynaecol 110 2003 808 818
84. H. von Hertzen, N.T. Huong, and G. Piaggio Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial Br J Obstet Gynaecol 117 2010 1186 1196
85. H. von Hertzen, G. Piaggio, and D. Wojdyla Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial Br J Obstet Gynaecol 116 2009 381 389
86. I.K. Warriner, D. Wang, and N.T. Huong Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal Lancet 377 2011 1155 1161
87. B. Winikoff, I.G. Dzuba, and M.D. Creinin Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial Obstet Gynecol 112 2008 1303 1310
88. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial Br J Obstet Gynaecol 107 2000 524 530
89. R. Kulier, N. Kapp, A.M. Gulmezoglu, G.J. Hofmeyr, L. Cheng, and A. Campana Medical methods for first trimester abortion Cochrane Database Syst Rev 11 2011 CD002855
90. Y. Swica, S. Raghavan, H. Bracken, R. Dabash, and B. Winikoff Review of the literature on patient satisfaction with early medical abortion using mifepristone and misoprostol Expert Rev Obstet Gynecol 6 2011 451 468
91. Allison P. Missing Data. Thousand Oaks, CA: Sage Publications, Inc; 2001.